National and Kapodistrian University of Athens
Radiolabeled magnetic nanoparticles for dual-modality disease imaging
Abstract
dc:descriptionDual modality contrast agents (DMCAs), such as radiolabeled magnetic nanoparticles (MNPs), are promising candidates for a number of diagnostic applications, since they combine the advantages of two different imaging modalities, namely single photon emission computed tomography (SPECT) or positron emission tomography (PET) with magnetic resonance imaging (MRI). The benefit of such a combination relates to the interpretation of the obtained imaging information in a more efficient and accurate way so that underlying diseases are reliably diagnosed at early stages. This aim is feasible since the proposed DMCA combines the advantages of each imaging technique, i.e. high sensitivity for SPECT/PET together with high spatial resolution for MRI. The development of such imaging tools bearing optimized imaging characteristics can lead to effective diagnosis and thus improved management and quality of life of the patient. Consequently, the aim of this PhD Thesis focuses on the development of two DMCAs, namely of a SPECT/MRI and of a PET/MRI DMCA and on their subsequent evaluation through in vivo experiments in animal models and in vitro ones with human blood cells. The specific DMCAs refer to MNPs (magnetite Fe3O4), surface-functionalized with the ligand 2,3-dicarboxypropane-1,1-diphosphonic acid (noted as DPD) and radiolabeled with the radionuclides 68Ga and 99mTc, noted as [68Ga]Ga-DPD-Fe3O4 and [99mTc]Tc-DPD-Fe3O4, respectively.To this effect we initially synthesized the parent (non-radiolabeled) DPD-Fe3O4, which by means of radiolabeling ultimately provided the [68Ga]Ga-DPD-Fe3O4 and the [99mTc]Tc-DPD-Fe3O4 DMCAs. Due to the obvious safety issues associated with these processes, they are conducted under special radioprotective precautions to reduce the risk of harm. Once the DMCAs are produced, we studied in detail their physical properties (crystallographic, morphological, magnetic and radioactive) by means of various experimental techniques. Specifically, we employ X-ray diffraction, dynamic light scattering, ζ-potential, optical microscopy (OM), atomic force microscopy (AFM), superconducting quantum interference device magnetometer, radioactivity counters and hematology analyzer (HA). To evaluate the in vivo potential of both [68Ga]Ga-DPD-Fe3O4 and [99mTc]Tc-DPD-Fe3O4 DMCAs, we performed biodistribution studies in normal and immunodeficient mice models. Also, PET/SPECT and MRI experiments were conducted on normal mice in order to further evaluate the biodistribution of these DMCAs, as well as their imaging efficacy on a comparative basis to that of the parent non-radiolabeled CA, DPD-Fe3O4. Given that the ultimate goal of our research is the in vivo PET/SPECT and MRI applications of these DMCAs in humans, here we have evaluated the [68Ga]Ga-DPD-Fe3O4 DMCA in in vitro experiments with donated human blood cells, namely red blood cells, white blood cells and platelets. To this end, conventional OM and advanced AFM imaging techniques were employed to access quantitative and qualitative information from the micrometer down to the nanometer scale.The results presented in this Thesis prove that both [68Ga]Ga-DPD-Fe3O4 and [99mTc]Tc-DPD-Fe3O4 DMCAs are promising candidates for future research in clinical trials.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karageorgou, Maria-Argyro
- Καραγεώργου, Μαρία-Αργυρώ
Subjects
dc:subject × 20- Σκιαγραφικοί παράγοντες διπλής απεικονιστικής ικανότητας
- Υπολογιστική τομογραφία μονοφωτονικής εκπομπής
- Τομογραφία εκπομπής ποζιτρονίου
- Τομογραφία μαγνητικού συντονισμού
- Πυρηνικός μαγνητικός συντονισμός
- Βιοσυμβατότητα
- Ραδιονουκλίδια
- Dual modality contrast agents
- Single photon emission computed tomography (SPECT)
- Positron emission tomography (PET)
- Magnetic resonance imaging (MRI)
- Nuclear magnetic resonance
- Biocompatibility
- Radionuclides
- Φυσική
- Φυσικές Επιστήμες
- Φυσική, διεπιστημονική προσέγγιση
- Physical Sciences
- Natural Sciences
- Physics, interdisciplinary
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51714